The use of enzymes in various industries has increased in recent times. Be it F&B, detergents, textile, pulp or wastewater treatment, enzymes serve as the primary substance for diverse industrial applications. Even niche, critical industries such as cosmetics, pharmaceuticals, biotechnology, diagnostics and biocatalysts are heavily relying on enzymes for manufacturing their products. As a result, high quality enzymes are in great demand across the world.
According to a recent study by Markets and Markets, the global enzymes market which is currently worth $12.1 billion is expected to be worth $16.9 billion by 2027, growing a CAGR of 6.8 percent during the forecast period. Asia-Pacific emerged as one of the regions with the strongest growth rate, and this can be attributed to growing industrialization, technological advancements such as enzyme engineering & green chemistry, and introduction of genetically modified enzymes in the region.
However, despite such encouraging factors, the industry is presently facing challenges in terms of regulatory compliances, quality and lack of proper knowledge about enzymes among the end users. While there are governing bodies such as Enzyme Technical Association (ETA) and Association of Manufacturers & Formulators of Enzyme Products (AMFEP), the industry lacks a uniform governing body with uniform regulations for various industrial enzymes. As a result, the enzyme companies often face delays in their manufacturing process.
Overcoming these hurdles and successfully offering a diverse variety of industrial enzymes is Fido Pharma. Headquartered in Panchkula, the company provides enzyme solutions and probiotics for various industrial applications across biopharmaceutical, fine chemicals, food & feed, and cosmetics industries. “Enzyme manufacturing industry is witnessing significant growth in India both in terms of technological advancements and availability. Initially, people were very much dependent on importing goods and enzymes from countries like China and Japan. But due to the current advancements and having latest practices in place, we are very strongly positioned to cater to every need of our consumers”, explains, Parbhat Singh, Managing Director, Fido Pharma.
Tejal Ashok Vispute, CEO & Managing Director, Fido Pharma, further adds, “We started this company three years ago. Initially, we faced lot of problems which is generally faced by all manufacturers such as trial & error, product modification, product development and scaling our R&D efforts. But we strived hard, and with the efforts of the entire team of Fido Pharma, we were able to introduce our first ever enzyme, which was Serratiopeptidase.
Later on, we introduced other enzymes such as Trypsin, Trypsin Chymotrypsin, Bromelain, Pepsin, Pancreatin, Fungal Diastate, L-Glutathione Reduced, Hyaluronic acid, Sodium Hyaluronate, Chondroitin sulfate and Alpha Amylase, to name a few”.
An ISO 9001: 2015,WHO-GMP,HACCP, HALAL, KOSHER, FSSAI, U.S. FDA certified company, Fido Pharma was established with a mission statement to manufacture quality enzymes, probiotics & probiotic blends at affordable prices, with prime focus on customer satisfaction, thorough R&D and continuous improvement in its products. It has a wide portfolio of products that includes Enzymes, Probiotics, Probiotics Blends, Nutraceuticals and Dietary Supplements. The company manufactures different classes of enzymes such as NSAIDS (Non-Steroidal Anti-Inflammatory Drug), Proteolytic Enzymes, Digestive Enzymes, and many others. However, Serratiopeptidase, Trypsin, Trypsin Chymotrypsin, Bromelain, Pepsin, Pancreatin and Fungal Diastase are the key flagship products that have garnered FIDO widespread prominence in the enzymes manufacturing industry.
Never compromising on its products’ quality, Fido Pharma ensures to only use best quality raw materials in manufacturing process. Additionally, keeping in mind the customers wanting vegetarian products, it manufactures enzymes using only microbial sources, thus making them completely vegetarian/vegan. The company also houses state-of-the-art infrastructure, technically advanced instruments and a dedicated R&D team through which it has developed many advanced molecules – vegetarian enzymes for instance – thus making it a pioneer in the field to manufacture such products.
“The major problem faced by customers in our industry is adulteration. We strategize to meet this requirement by emphasizing on quality over quantity. As a quality-oriented company, we always work on giving our clients consistent quality at better prices. We have a specialized team (Quality Control Team) to help our customers with their doubts regarding assay, formulation and other queries. It’s not the sale, but the aftersales service which helps our company stand-out from others”, explains Parbhat Singh.
Fido Pharma primarily functions on four core values – quality through compliance at best cost, creditable integrity & ethical behavior, performance driven work culture, and collaboration, effective team work & mutual respect. Acting as the main pillar of growth are its two directors Prabhat and Tejal. Known as the ‘Problem Solver’ at FIDO, Prabhat has 13 years of experience in the pharmaceutical industry and has developed many herbal extracts such as coleus forskolin extract, curcumin extract and green coffee bean extract, to name a few. Currently, he oversees the business development, customer relations and procurement operations at FIDO. On the other hand. Tejal comes with over nine years of pharmaceutical industry experience and takes care of R&D, regulatory affairs and all technical aspects of the company. The combined efforts of Prabhat and Tejal, along with the technically adept team members has enabled Fido Pharma carve a niche for itself in the enzymes manufacturing domain.
Due to the current advancements and having latest practices in place, we are very strongly positioned to cater to every need of our consumers
When asked about the future roadmap of the company, the duo concludes, “From initially servicing only domestic clients, we now have grown to a position where we are exporting our products to over 20 countries such as US, Korea, China, and Uzbekistan. The enzymes market, especially the fertilization industry, will revolutionize the world in the near future. So, we will focus more on that and envision becoming the global leader in the enzymes manufacturing industry”.
Key Management
• Parbhat Singh, Managing Director
A kind hearted person with a helping nature, Prabhat holds a Bachelorette in Science has 12 years of experience in the pharmaceutical industry and is well known for his unique approach towards solving various problems. He is also an eminent personality in the Indian herbal extracts, Probiotics and enzymes sector.
• Tejal Ashok Vispute, CEO and Managing Director
Tejal holds a Masters in Pharmacy and has five years of experience in diverse aspects of the pharmaceutical industry.
.jpg "Artificial Intelligence to Revolutionize Advanced Chip Design")
